Mettler-Toledo International (NYSE:MTD) Insider Sells $334,784.88 in Stock

Mettler-Toledo International, Inc. (NYSE:MTD) insider Gerry Keller sold 236 shares of the business’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total value of $334,784.88. Following the sale, the insider owned 159 shares in the company, valued at $225,554.22. The trade was a 59.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Mettler-Toledo International Stock Up 3.4%

Shares of Mettler-Toledo International stock traded up $50.51 during midday trading on Tuesday, hitting $1,520.65. The company had a trading volume of 91,835 shares, compared to its average volume of 164,760. The stock has a market cap of $31.06 billion, a price-to-earnings ratio of 38.51, a PEG ratio of 4.19 and a beta of 1.41. The company has a fifty day simple moving average of $1,351.79 and a 200 day simple moving average of $1,265.11. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the previous year, the firm earned $10.21 EPS. Mettler-Toledo International’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently issued reports on MTD shares. JPMorgan Chase & Co. upped their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Evercore ISI boosted their price target on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Citigroup increased their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday, November 10th. Stifel Nicolaus lifted their target price on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Finally, Bank of America upped their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $1,406.50.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. CIBC Bancorp USA Inc. acquired a new position in Mettler-Toledo International in the third quarter valued at approximately $3,496,000. Achmea Investment Management B.V. grew its stake in shares of Mettler-Toledo International by 1.3% during the 3rd quarter. Achmea Investment Management B.V. now owns 32,920 shares of the medical instruments supplier’s stock worth $40,413,000 after purchasing an additional 409 shares during the period. Sunbelt Securities Inc. increased its holdings in shares of Mettler-Toledo International by 6,780.0% during the 3rd quarter. Sunbelt Securities Inc. now owns 344 shares of the medical instruments supplier’s stock valued at $422,000 after purchasing an additional 339 shares in the last quarter. Captrust Financial Advisors lifted its stake in shares of Mettler-Toledo International by 0.6% in the 3rd quarter. Captrust Financial Advisors now owns 21,462 shares of the medical instruments supplier’s stock valued at $26,347,000 after purchasing an additional 118 shares during the period. Finally, Coldstream Capital Management Inc. boosted its holdings in Mettler-Toledo International by 5.1% during the third quarter. Coldstream Capital Management Inc. now owns 371 shares of the medical instruments supplier’s stock worth $456,000 after buying an additional 18 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.